# PG&E Corp: Form 10-Q for the period ended Sep 30, 2022

- Company: [PG&E Corp](/companies/pcg.md) (CIK 1004980)
- Form: 10-Q
- Filed: 2022-10-27
- Accepted by EDGAR: Oct 27, 2022, 08:06 ET
- Period: 2022-09-30
- Accession: 0001004980-22-000133
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1004980/000100498022000133/pcg-20220930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1004980/000100498022000133/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-07-01 to 2022-09-30 | $5.39bn | us-gaap:Revenues |
| Revenue | 9 months, 2022-01-01 to 2022-09-30 | $16.31bn | us-gaap:Revenues |
| Operating income | 3 months, 2022-07-01 to 2022-09-30 | $726.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2022-01-01 to 2022-09-30 | $1.71bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2022-07-01 to 2022-09-30 | $525.0m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2022-01-01 to 2022-09-30 | $1.35bn | us-gaap:InterestExpense |
| Income tax | 3 months, 2022-07-01 to 2022-09-30 | −$97.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2022-01-01 to 2022-09-30 | −$629.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-07-01 to 2022-09-30 | $459.0m | us-gaap:ProfitLoss |
| Net income | 9 months, 2022-01-01 to 2022-09-30 | $1.30bn | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2022-07-01 to 2022-09-30 | $0.21 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2022-01-01 to 2022-09-30 | $0.60 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-07-01 to 2022-09-30 | $0.23 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2022-01-01 to 2022-09-30 | $0.65 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-07-01 to 2022-09-30 | 2,132,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2022-01-01 to 2022-09-30 | 2,132,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2022-01-01 to 2022-09-30 | $2.71bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2022-01-01 to 2022-09-30 | $7.41bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2022-09-30 | $262.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-09-30 | $12.21bn | us-gaap:AssetsCurrent |
| Total assets | at 2022-09-30 | $117.01bn | us-gaap:Assets |
| Current liabilities | at 2022-09-30 | $14.03bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2022-09-30 | $47.85bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2022-09-30 | $1.03bn | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2022-09-30 | $1.79bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2022-09-30 | $22.23bn | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1004980/000100498022000133/pcg-20220930.htm

Filed Oct 27, 2022.
Source: SEC EDGAR, the filing index for accession 0001004980-22-000133. Last ingested by Listed: Nov 14, 2026, 23:58 ET. No prices; not investment advice.
